News by Subject
News by Disease
News by Date
Post Your News
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
US & Canada
Post an Event
News | News By Subject | News by Disease |
News By Date | Search News
MyoScience Inc. Release: iovera Treatment for Dynamic Wrinkles Now Approved in Canada
7/18/2013 7:01:26 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
iovera Treatment for Dynamic Wrinkles Now Approved in Canada
REDWOOD CITY, Calif., July 18, 2013 (GLOBE NEWSWIRE) -- iovera°, the world's first toxin-free treatment for dynamic wrinkles utilizing the body's natural response to cold, has received regulatory approval in Canada. Developed by myoscience, inc. in California, the iovera° system targets dynamic forehead wrinkles precisely using Focused Cold TherapyTM, an advanced technology that works immediately to temporarily reduce the appearance of wrinkles without leaving any toxins or chemicals behind in the body. The treatment is currently available in the European Union and will be available in Canada soon.
People who want to treat their forehead wrinkles but are uncomfortable with previously available treatments now have a new option with the iovera° system. The treatment only takes about 20 minutes, and is an exciting new solution for those who want a quick toxin-free treatment for dynamic wrinkles.
Clint Carnell, CEO of myoscience, can see the excitement that iovera° is already generating with its launch in the EU. "We developed iovera° in partnership with some of the world's leading physicians. There is powerful consumer demand for iovera° because it offers a wrinkle solution that has no toxins and no wait for results, so there's no worry for patients about getting back to their regular lifestyle."
An early partner and physician using iovera° in his clinic in Paris, France, Dr. Patrick Trevidic says: "I know from experience that there are patients who have hesitations about using botulinum toxin. They still want to treat their wrinkles : iovera° for these patients is a more comfortable option because it injects nothing into the body. It enables me to better serve more of my patients and is a welcome addition to my aesthetic treatment toolbox. Best of all the results are seen immediately which is very exciting."
Silicon Valley, California-based myoscience is a privately-held medical device company committed to making its platform technology, Focused Cold TherapyTM, the standard of care for the treatment of peripheral nerve conditions. Focused Cold Therapy is currently approved in Europe and Canada for temporary wrinkle reduction, temporary pain reduction and treatment of dermatologic conditions. The myoscience technology has also been cleared in the United States for use in pain management and general surgical use. For more information, please visit www.myoscience.com.
The myoscience logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13581
Help employers find you! Check out all the jobs and post your resume.